Reckitt Benckiser Group Earnings Calls
| Release date | Mar 05, 2026 |
| EPS estimate | $2.54 |
| EPS actual | $2.48 |
| EPS Surprise | -2.36% |
| Revenue estimate | 9.787B |
| Revenue actual | 9.795B |
| Revenue Surprise | 0.0786% |
| Release date | Jun 30, 2025 |
| EPS estimate | $2.22 |
| EPS actual | $1.91 |
| EPS Surprise | -13.96% |
| Revenue estimate | 9.624B |
| Revenue actual | 9.513B |
| Revenue Surprise | -1.16% |
| Release date | May 02, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Dec 31, 2024 |
| EPS estimate | $1.93 |
| EPS actual | $0.501 |
| EPS Surprise | -74.04% |
| Revenue estimate | 8.795B |
| Revenue actual | 8.76B |
| Revenue Surprise | -0.397% |
Last 4 Quarters for Reckitt Benckiser Group
Below you can see how RBGPF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Dec 31, 2024 |
| Price on release | $61.48 |
| EPS estimate | $1.93 |
| EPS actual | $0.501 |
| EPS surprise | -74.04% |
| Date | Price |
|---|---|
| Dec 24, 2024 | $62.29 |
| Dec 26, 2024 | $62.29 |
| Dec 27, 2024 | $62.33 |
| Dec 30, 2024 | $64.58 |
| Dec 31, 2024 | $61.48 |
| Jan 02, 2025 | $61.78 |
| Jan 03, 2025 | $61.78 |
| Jan 06, 2025 | $61.78 |
| Jan 07, 2025 | $61.78 |
| 4 days before | -1.30% |
| 4 days after | 0.491% |
| On release day | 0.491% |
| Change in period | -0.82% |
| Release date | May 02, 2025 |
| Price on release | $70.01 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Apr 28, 2025 | $63.42 |
| Apr 29, 2025 | $65.63 |
| Apr 30, 2025 | $65.63 |
| May 01, 2025 | $70.01 |
| May 02, 2025 | $70.01 |
| May 05, 2025 | $69.00 |
| May 06, 2025 | $68.60 |
| May 07, 2025 | $68.60 |
| May 08, 2025 | $68.60 |
| 4 days before | 10.40% |
| 4 days after | -2.01% |
| On release day | -1.44% |
| Change in period | 8.18% |
| Release date | Jun 30, 2025 |
| Price on release | $72.85 |
| EPS estimate | $2.22 |
| EPS actual | $1.91 |
| EPS surprise | -13.96% |
| Date | Price |
|---|---|
| Jun 24, 2025 | $70.21 |
| Jun 25, 2025 | $70.21 |
| Jun 26, 2025 | $69.77 |
| Jun 27, 2025 | $69.77 |
| Jun 30, 2025 | $72.85 |
| Jul 01, 2025 | $71.51 |
| Jul 02, 2025 | $72.13 |
| Jul 03, 2025 | $72.13 |
| Jul 07, 2025 | $70.36 |
| 4 days before | 3.77% |
| 4 days after | -3.42% |
| On release day | -1.84% |
| Change in period | 0.220% |
| Release date | Mar 05, 2026 |
| Price on release | $81.74 |
| EPS estimate | $2.54 |
| EPS actual | $2.48 |
| EPS surprise | -2.36% |
| Date | Price |
|---|---|
| Feb 27, 2026 | $83.96 |
| Mar 02, 2026 | $83.96 |
| Mar 03, 2026 | $83.96 |
| Mar 04, 2026 | $81.74 |
| Mar 05, 2026 | $81.74 |
| Mar 06, 2026 | $81.74 |
| Mar 09, 2026 | $72.19 |
| Mar 10, 2026 | $75.07 |
| Mar 11, 2026 | $74.17 |
| 4 days before | -2.65% |
| 4 days after | -9.25% |
| On release day | 0% |
| Change in period | -11.65% |
Reckitt Benckiser Group Earnings Call Transcript Summary of Q4 2025
Reckitt delivered solid FY2025 results driven by Emerging Markets and execution of its Fuel for Growth program. Core Reckitt like-for-like net revenue grew 5.2% (volumes +1.5%, price/mix +3.7%), with group adjusted operating profit up 5.3% at constant currency and Core Reckitt margins expanding 90 bps to 26.7%. Emerging Markets was the growth engine (Core EM +14.6%) with China and India notably strong; Intimate Wellness (Durex/Intima) and Dettol were key outperformers. The company is increasing CapEx (GBP 592m in 2025) to strengthen and localize supply chain capacity (new lines/factories in China, North Carolina, Poland, Thailand). Fuel for Growth delivered material fixed-cost savings (group fixed costs 19.4% of revenue in 2025) and enabled stepped-up brand equity investment; management expects to largely offset stranded costs from the Essential Home divestment through the program in 2026 and to exit 2027 with a fixed cost base below 19%. Mead Johnson Nutrition grew 3.8% in 2025 and remains subject to strategic review; Essential Home was divested and GBP 1.6bn returned to shareholders (plus total shareholder returns of GBP 2.3bn including buybacks/dividends). FY2026 guidance: Core Reckitt like-for-like net revenue growth 4–5% (led by Emerging Markets), Q1 to be weaker due to seasonality, CapEx guidance ~4% of revenue, leverage expected to rise toward ~2.5x net debt/EBITDA by H1 2026 before returning lower. Key investor considerations: strong Emerging Markets momentum and margin expansion via Fuel for Growth; higher near-term leverage and elevated CapEx; exposure to seasonal OTC volatility (soft season impacted 2025 shares/volumes) and a tough European consumer/promotional environment; ongoing returns to shareholders via progressive dividend policy and continued buybacks.
Sign In
Buy RBGPF